Tag: Cancer: Prostate
Apalutamide Active in Castration-Resistant Prostate Cancer
Apalutamide prolongs metastasis-free survival in non-metastatic castration-resistant prostate cancer
Obesity, Metabolic Syndrome Ups Risk of Recurrent Prostate Cancer
Following radical prostatectomy, higher BMI increases risk of recurrence for prostate cancer
Mediterranean Diet May Lower Risk of Aggressive Prostate CA
Prudent or Western pattern diets had no association with prostate cancer risk
Mortality Up for Some Cancers in Urban-Dwelling Native Americans
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
Less Frequent Biopsy May Be Option in Prostate Cancer Care
Consequences of biennial versus annual biopsies similar during active surveillance
Heterogeneity of PET/CT Imaging Phenotype Prognostic in mCRPC
Assessments of androgen receptor, glycolysis prognostic in castration-resistant prostate Cancer
Genetic Variant Tied to Prostate Cancer Outcomes
Time to metastasis, length of survival vary by number of HSD3B1 (1245C) variant alleles
Increase in Number of Centers Doing Robotic Prostatectomy
Radical prostatectomy centers that closed from '10 to '14 more likely in areas with strong competition
No Difference in Toxicity for 6-, 2-Fraction HDR in Prostate Cancer
Urinary, sexual toxicity similar with 6-, 2-fraction high-dose-rate brachytherapy regimen
Re-Analysis Shows Screening Reduces Prostate CA Mortality
In re-analysis, screening conferred 7 to 9 percent reduction in risk in ERSPC and PLCO trials
